Feasibility and cosmetic outcome of oncoplastic surgery in breast cancer treatment  by Sherwell-Cabello, Santiago et al.
Cirugía y Cirujanos. 2015;83(3):199--205
www.amc.org.mx www.elsevier.es/circir
CIRUGÍA  y  CIRUJANOS
Órgano de difusión científica de la Academia Mexicana de Cirugía
Fundada en 1933
ORIGINAL ARTICLE
Feasibility  and cosmetic  outcome  of  oncoplastic
surgery in breast  cancer  treatment
Santiago Sherwell-Cabelloa,∗, Antonio Maffuz-Aziza, Felipe Villegas-Carlosa,
Carlos  Domínguez-Reyesa, Sonia Labastida-Almendarob, Sergio Rodríguez-Cuevasa
a Departamento  de  Cirugía  Oncológica  de  Mama,  Instituto  de  Enfermedades  de  la  Mama,  FUCAM  A.C.,  Coyoacán  D.F.,  México
b Departamento  de  Investigación  y  Bioestadística,  Instituto  de  Enfermedades  de  la  Mama,  FUCAM  A.C.,  Coyoacán  D.F.,  México
Received 30  June  2014;  accepted  19  November  2014
KEYWORDS
Oncoplastic  surgery;
Breast  cancer;
Treatment
Abstract
Background:  Breast  cancer  is  the  leading  oncological  cause  of  death  in  Mexican  women  over
25 years  old.  Given  the  need  to  improve  postoperative  cosmetic  results  in  patients  with  breast
cancer, oncoplastic  surgery  has  been  developed,  which  allows  larger  tumour  resections  and
minor cosmetic  alterations.
Objective:  To  determine  the  oncological  feasibility  and  cosmetic  outcome  of  oncoplastic
surgery at  the  Instituto  de  Enfermedades  de  la  Mama,  FUCAM,  AC.
Material  and  methods: A  review  was  conducted  from  January  2010  to  July  2013,  which  included
patients  with  breast  cancer  diagnosis  treated  with  conventional  breast-conserving  surgery  or
with oncoplastic  surgery  in  the  Instituto  de  Enfermedades  de  la  Mama,  FUCAM  AC.  Clinical  and
histopathological  parameters  were  compared  between  the  two  groups,  and  a  questionnaire  of
cosmetic satisfaction  and  quality  of  life  was  applied.
Results:  Of  the  171  patients  included,  95  of  them  were  treated  with  conventional  breast-
conserving  surgery  and  76  with  oncoplastic  surgery.  Pathological  tumour  size  was  signiﬁcantly
larger in  patients  treated  with  oncoplastic  surgery  (p  =  0.002).  There  were  no  differences  found
between  the  groups  as  regards  the  number  of  patients  with  positive  surgical  margin,  the  rate
of complications,  and  cosmetic  satisfaction.
Conclusion:  This  study  demonstrates  the  oncological  feasibility  and  high  cosmetic  satisfaction
of oncoplastic  surgery  with  minimal  psycho-social  impact  on  patients.
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Factibilidad  y  resultado  estético  de  la  cirugía  oncoplástica  en  el  tratamiento  de
cáncer  de  mama
Resumen
Antecedentes:  El  cáncer  de  mama  representa  la  principal  causa  de  muerte  de  origen  oncológico
en mujeres  mexicanas  mayores  de  25  an˜os.  Ante  la  necesidad  de  mejorar  los  resultados  estéticos
posquirúrgicos  en  las  pacientes  con  cáncer  de  mama,  se  ha  desarrollado  la  cirugía  oncoplástica,
la cual  permite  realizar  cirugía  conservadora  en  tumores  de  mayor  taman˜o  con  menor  defecto
estético.
Objetivo: Conocer  la  factibilidad  de  la  cirugía  oncoplástica,  su  seguridad  oncológica,  así  como
el resultado  estético  en  el  Instituto  de  Enfermedades  de  la  Mama,  FUCAM  A.C.
Materiales  y  métodos: Revisión  ambispectiva  desde  enero  del  2010  hasta  julio  del  2013  en
pacientes  con  diagnóstico  de  cáncer  de  mama  tratadas  con  cirugía  conservadora  convencional
o con  patrones  oncoplásticos  en  el  Instituto  de  Enfermedades  de  la  Mama,  FUCAM  A.C.  Se  com-
pararon entre  ambos  grupos  parámetros  clínicos  e  histopatológicos  y  se  aplicó  un  cuestionario
de satisfacción  estética  y  de  calidad  de  vida.
Resultados:  Se  incluyó  a  171  pacientes,  95  fueron  tratadas  con  cirugía  conservadora  conven-
cional y  76  utilizando  patrones  oncoplásticos.  El  taman˜o  tumoral  determinado  por  enfermedad
fue signiﬁcativamente  mayor  en  las  pacientes  tratadas  con  cirugía  oncoplástica  (p  =  0.002),
sin diferencias  entre  ambos  grupos  con  respecto  al  número  de  pacientes  con  borde  quirúrgico
positivo ni  en  la  tasa  de  complicaciones.  Ambos  con  un  alto  grado  de  satisfacción  estética.
Conclusión:  Este  estudio  demuestra  la  factibilidad  y  alta  satisfacción  estética  de  la  cirugía
oncoplástica  con  un  mínimo  impacto  psicosocial  en  las  pacientes.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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treated  with  conventional  conservative  surgery  or  oncoplas-ackground
reast  cancer  is  the  main  oncological  source  cause  of  death
n  Mexican  women  over  25  years  of  age.1 It  is  estimated
hat  12%  of  women  will  develop  breast  cancer  during  their
ifetime.2 In  2014,  more  than  230,000  new  cases  of  breast
ancer  were  diagnosed  in  the  United  States  and  nearly
0,000  died  that  year  from  this  cause.2,3
Mastectomy  has  for  a  long  time  been  the  treatment
f  choice  for  breast  cancer.  Currently,  conservative  breast
urgery  with  added  radiotherapy  is  fully  accepted  as  treat-
ent  for  breast  cancer  in  early  stages.4 In  several  studies  it
as  been  proven  that  conservative  surgery  presents  no  dif-
erence  in  global  survival  and  the  period  free  from  disease
s  compared  to  mastectomy.5,6
Despite  the  increase  in  the  frequency  of  breast  preser-
ation  in  the  treatment  of  breast  cancer,  20--30%  of  these
atients  will  present  an  unfavourable  aesthetic  result,  espe-
ially  if  wide  excisions  are  required,  mainly  above  20%
f  the  total  volume  of  the  breast,  or  tumours  located  in
nfavourable  areas,  such  as  the  internal  quadrants  of  the
reast.7,8
Given  the  increasing  need  to  improve  aesthetic  results
n  patients  with  breast  cancer,  several  authors  have  made
fforts  during  the  past  decades  to  offset  this  adverse  result
ithout  compromising  the  oncological  goals.  According  to
rban  et  al.  in  1980,  Jean-Yves  Peitt  and  Michel  Abbes
pplied  plastic  surgery  techniques  in  conservative  breast
urgery.  Later,  the  German  Werner  Audrescht  coined  the
erm  oncoplastic  surgery,  which  was  popularised  by  French
urgeon  Krishna  Clough  in  2003.8
t
F
tIn  these  last  years,  oncoplastic  surgery  has  been  used
ore  frequently  in  the  treatment  with  breast  cancer.9 It is  an
nnovative  approach  which  allows  larger  tumour  resections
ith  wide  margins  and  fewer  aesthetic  consequences.10 It
s  especially  indicated  when  more  than  20%  of  the  breast
olume  has  to  be  resected,  when  there  is  macromasty,  ptosis
r  asymmetry,  in  tumours  with  central,  medial  or  inferior
ocation,  or  when  there  are  prior  surgeries  in  the  affected
reast.8
Oncoplastic  surgery  has  notably  improved  the  aesthetic
esult  of  patients  treated  for  breast  cancer,  since  wider
esection  margins  can  be  obtained  through  these  techniques
s  compared  to  conservative  surgery,  with  a  decrease  in  the
ecurrence  rate  and  improved  survival.10,11
bjective
hrough  this  study,  the  goal  is  to  explore  the  feasibility  of
ncoplastic  surgery,  its  oncological  safety,  as  well  as  the  aes-
hetic  result  at  the  Instituto  de  Enfermedades  de  la  Mama,
UCAM  A.C.
aterials and methods
n  ambispective  study  was  carried  out  from  1  January  2010
o  31  July  2013.  All  patients  with  breast  cancer  diagnosisic  patterns  at  the  Instituto  de  Enfermedades  de  la  Mama,
UCAM  A.C.,  with  a  complete  clinical  ﬁle  and  who  answered
he  aesthetic  satisfaction  questionnaire,  whether  in  person
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Table  2  Gland  size.
Gland
size
Conservative
surgery
n  (%)
Oncoplastic
surgery
n  (%)
p
A  6  (6.3)  5  (6.6)  0.231
B 74  (77.9)  52  (68.4)
C 12  (12.6)  15  (19.7)
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it  (p  <  0.001).  Of  the  171  patients  included  in  the  study,  95
were  treated  with  conventional  conservative  surgery  and  76
using  oncoplastic  patterns.  28  of  those  had  a  contralateral
Table  3  Clinical  stages  (TNM).
Conservative
surgery
n  (%)
Oncoplastic
surgery
n  (%)
pFeasibility  and  cosmetic  outcome  of  oncoplastic  surgery  
or  via  telephone,  were  included.  Those  who  did  not  con-
tinue  their  follow-up  at  the  institute  were  eliminated  from
the  study.  Clinical  and  histopathological  parameters  were
evaluated  between  both  groups,  as  well  as  the  degree  of
aesthetic  satisfaction  and  quality  of  life  of  the  European
Organisation  for  Research  and  Treatment  of  Cancer  ((EORTC
QLQ-C30),  FACT-B  questionnaire  at  FACIT.org  and  Breast-Q
through  the  questionnaire  answering  ‘‘1:  none,  2:  slightly,
3:  regularly,  4:  a  lot,  or  5:  full’’,  as  considered,  to  each
question.12 Treatments  were  established  during  the  tumours
session  pursuant  to  the  treatment  standards  of  international
medical  guidelines.
Baseline  characteristics  of  both  groups  are  expressed  as
means  and  typical  deviation  (standard  deviation).  In  the
invariable  analysis,  the  means  were  compared  through  a
non-parametric  Mann--Whitney  U  test  or  the  t-Student  test
in  the  case  of  variables  with  normal  distribution.
Also,  proportions  with  their  related  95%  conﬁdence  inter-
vals  were  obtained.  The  result  was  considered  statistically
signiﬁcant  if  the  p  value  was  lower  than  0.05.
Results
From  January  2010,  278  patients  were  treated  with  conser-
vative  surgery  at  Instituto  de  Enfermedades  de  la  Mama,
FUCAM,  A.C.  Of  those,  171  patients  were  included  in  this
study,  who,  in  addition  to  having  been  treated  with  con-
servative  surgery  with  or  without  oncoplastic  pattern,  had
the  full  ﬁle,  continued  under  follow-up  at  the  institute  and
answered,  whether  in  person  or  over  the  phone,  the  estab-
lished  aesthetic  satisfaction  questionnaire.
Of  the  171  patients  included,  95  were  treated  with
conventional  conservative  surgery  and  76  using  oncoplas-
tic  patterns.  No  signiﬁcant  differences  were  found  between
the  groups  as  regards  age,  comorbidities,  use  of  tobacco
and  the  body  mass  index  (Table  1).  The  mean  age  of
patients  included  in  the  study  was  55.6  years  (range  of  27--84
years).  The  mean  of  follow-up  was  19.6  months  (range  2--44
months).
Clinical parameters
The  gland  size  of  patients  was  determined  through  the  bra
cup  size  used,  and  no  signiﬁcant  differences  were  found
between  both  groups  (p  =  0.231)  (Table  2).Breast  regions  established  to  determine  tumour  loca-
tion  were  the  following:  retroareolar  region,  super-external
quadrant,  infero-external  quadrant,  infero-internal  quad-
rant  and  supero-internal  quadrant.  In  both  groups,  the
Table  1  Demographical  data.
Conservative
surgery
Oncoplastic
surgery
p
Age  (years)  56.6  54.2  0.786
Comorbidities  n  (%)
No  87  (91.6)  65  (85.5)
Yes  8  (8.4)  11  (14.5)  0.61
No signiﬁcant differences were observed between both groups
as regards demographical data.D 3  (3.2)  4  (5.3)
umour  location  was  homogeneous  (p  =  0.138).  The  supero-
xternal  quadrant  was  the  most  common  site  in  both
roups.
According  to  the  AJCC/TNM  classiﬁcation  system,  the
umour  clinical  stage  of  all  patients  was  determined  tak-
ng  into  consideration  the  tumour  size  and  axillary  lymph
odes,  in  the  absence  of  metastasis.13 It  was  proved
hat  in  the  group  of  oncoplastic  surgery,  larger  tumours
ere  included  as  compared  to  the  conventional  con-
ervative  surgery  group  (p  =  0.009),  but  no  differences
ere  found  between  the  groups  as  regards  lymph  nodes
tate  (p  =  0.34).  Clinical  stages  were  signiﬁcantly  higher
n  patients  with  oncoplastic  surgery.  This  was  due  to  the
ize  of  the  tumour,  not  the  lymph  node  status  (p  =  0.017)
Table  3).
reatment
he  treatment  of  each  patient  was  determined  during
umour  sessions.  While  10  patients  (10.5%)  of  the  conserva-
ive  surgery  group  received  neoadjuvant  chemotherapy,  31
atients  (40.8%)  treated  with  oncoplastic  surgery  receivedTumour  size
T0  13  (13.7) 3  (3.9)  0.009
T1 44  (46.3)  26  (34.2)
T2  34  (35.8)  44  (55.3)
T3  4  (4.2)  5  (6.6)
Lymph  node  status
N0 77  (81.1)  59  (77.6)  0.034
N1 16  (16.8)  12  (15.8)
N2  2  (2.1)  5  (6.6)
Clinical  stage
0  13  (13.7)  2  (2.6)  0.017
I 41  (43.2)  24  (31.6)
IIA  30  (31.6)  34  (44.7)
IIB  8  (8.4)  10  (13.2)
IIIA  3  (3.2)  6  (7.9)
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Figure  1  Right  breast  tumour  in  10  radius  treated  with  lateral  branch  pattern  and  symmetrisation  of  contralateral  breast  with
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Table  4  Oncoplastic  patterns.
n
Oncoplastic  pattern  I 15
Lateral  branch  pattern 21
Internal  rotation  pattern 1
Circular  pattern 13
Grissotti  8
Vertical  branch  pattern 13
Double  branch  pattern  3
Total  76
F
oertical branch  pattern.
ymmetrisation.  Oncoplastic  patterns  used  were  determined
uring  the  tumours  session  based  on  the  location  of  the
umour  in  the  breast14 (Table  4)  (Figs.  1  and  2).
Regarding  adjuvant  treatments  administered,  it  was
ound  that  57  patients  of  the  total  received  adjuvant
hemotherapy,  28  patients  had  tumours  with  Her-2  over-
xposure,  and  therefore  received  anti-Her-2  therapy  with
rastuzumab,  and  138  patients  received  hormonal  therapy
ith  tamoxifen  or  aromatase  inhibitors,  indicated  in  all
atients  with  positive  oestrogen  or  progesterone  receptors,
s  standard  treatment.  Out  of  the  total  patients  included
n  the  study,  169  received  radiotherapy,  whether  externally
ith  increase  in  the  bed,  or  intraoperatively.  In  2  patients,
adiotherapy  was  not  considered  given  the  advanced  age  and
avourable  clinical  and  histopathological  characteristics.
igure  2  Tumour  in  right  breast  in  12  radius  and  moderate  breast  
f contralateral  breast  with  the  same  pattern.Source: Based on Acea Nebril.14
ptosis  treated  with  vertical  branch  pattern  and  symmetrisation
Feasibility  and  cosmetic  outcome  of  oncoplastic  surgery  
Table  5  Surgical  parameters.
Conservative
surgery
Oncoplastic
surgery
p
Surgical  time  (min)  128  134.4  0.5
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months,  we  prove  that  no  signiﬁcant  differences  were  foundBleeding  (ml)  86.1  112.4  0.008
Surgical parameters
It  has  been  determined  that  patients  treated  with  oncoplas-
tic  surgery  had  a  higher  operating  time  with  no  signiﬁcant
difference  with  the  conservative  surgery  group  (p  =  0.5).  On
the  other  hand,  the  use  of  oncoplastic  patterns  presented
more  intraoperative  bleeding  as  compared  to  patients
treated  with  conservative  surgery  only,  but  no  cases  requir-
ing  blood  transfusion  afterwards  were  recorded  (Table  5).
The  hospital  stay  was  a  maximum  of  one  day  in  161  patients
and  2  days  in  the  rest.
Pathological anatomy
The  tumour  size  determined  by  pathology  was  signiﬁ-
cantly  higher  in  patients  treated  with  oncoplastic  surgery
(p  =  0.002).  While  the  mean  size  in  patients  treated  with
conservative  surgery  was  1.4  cm  with  a  maximum  size  of
4.4  cm.  In  the  group  with  oncoplastic  surgery,  it  was  2  cm
with  a  maximum  of  6  cm  resected.
Regarding  the  mean  of  the  closest  surgical  margin,  it
was  9.6  mm  in  patients  with  conservative  surgery  with  a
maximum  of  25  mm  and  7.1  mm  for  patients  treated  with
oncoplastic  surgery,  but  margins  of  up  to  29  mm  were
obtained  in  this  group  (p  =  0.006).  On  the  other  hand,  only  2
patients  of  each  group  presented  positive  tumour  border  in
the  ﬁnal  pathology  report,  and  required  broadening  of  the
surgical  treatment  (p  =  0.602).Only  one  recurrence  was  found  in  the  group  of  conserva-
tive  surgery,  while  in  the  group  of  oncoplastic  surgery,  none
has  been  detected  so  far.
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Table  6  Aesthetic  satisfaction  and  psychosocial  impact  questionn
1.  Are  you  satisﬁed  with  the  aesthetic  result  of  your
surgery?
2. Are  you  satisﬁed  with  the  scar  from  the  surgery?  
3. Are  you  satisﬁed  with  the  appearance  of  the  breast?  
4. Are  you  satisﬁed  with  the  size  of  the  breast?  
5. Are  you  satisﬁed  with  your  current  quality  of  life?  
6. Are  you  satisﬁed  with  the  sensitivity  of  the  nipple  and
the areola?
7. Is  there  a  relevant  similarity  with  the  contralateral
breast?
8. Do  you  consider  the  inﬂammatory  process  of  the  breast
after the  surgery  is  normal?
9. Do  you  feel  conﬁdent  to  appear  in  public?  
10. Do  you  have  the  same  self-esteem  after  the  surgery  as
before?203
omplications
everal  complications  were  recorded  regarding  the  surgical
rocedure  per  se,  which  will  be  recorded  in  the  ﬁle.  These
ere  wound  infection,  dehiscence,  reoperation  for  posi-
ive  margins,  haematoma,  seroma,  cutaneous  necrosis,  AP
ecrosis,  dystrophic  scar,  severe  pain  or  asymmetry  as  com-
ared  to  contralateral  breast.  In  global  terms,  16  patients
16.8%)  of  the  conservative  surgery  group  and  14  (18.4%)  of
he  oncoplastic  surgery  group  had  some  type  of  complication
p  =  0.471).
uestionnaire
s  regards  the  questionnaire,  no  signiﬁcant  differences  were
ound  between  both  groups  (p  =  0.256),  with  a  high  level  of
esthetic  acceptance  and  a mild  social  and  psychological
ffectation  of  patients  (Table  6).
iscussion
ncoplastic  surgery  techniques  have  had  a  major  applica-
ion  in  the  treatment  of  breast  cancer  for  the  purposes  of
ecreasing  the  incidence  of  aesthetic  defects  caused  by  the
astectomy  and  the  conservative  surgery.  Up  to  20%  of  cases
ere  reported  in  patients  treated  with  this  method.9
Clough  et  al.7 have  divided  or  classiﬁed  oncoplastic
urgery  in  2  levels,  I  and  II.  The  ﬁrst  is  indicated  when
he  volume  to  be  resected  is  less  than  20%  and  does  not
equire  skin  removal  or  mammoplasty,  in  cases  where  there
s  macromasty,  ptosis  or  asymmetry  as  compared  to  con-
ralateral  breast.  Level  II  is  carried  out  when  20  to  50%  of
he  breast  volume  has  to  be  removed  and  breast  remodelling
s  required.
In  this  comparative  study,  with  a  follow-up  mean  of  19.6etween  both  groups  as  regards  age,  comorbidities  and  the
se  of  tobacco.  In  addition,  there  was  also  no  signiﬁcant
ifference  in  the  gland  size  of  both  groups.
aire.
Conservative  surgery  Oncoplastic  surgery
4.72  4.81
4.73  4.61
4.67  4.74
4.83  4.8
4.81  4.77
4.61  4.68
4.85  4.92
4.78  4.88
4.91  4.96
4.69  4.79
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The  treatments  of  each  patient  were  determined
uring  the  tumour  sessions  at  the  institute.  Given  the
bsence  of  factors  contraindicating  the  conservative
urgery,  the  proper  breast-tumour  relation  was  key  in  deter-
ining  the  possibility  of  breast  preservation.
A  higher  proportion  of  patients,  nearly  62%  in  the  group
f  oncoplastic  surgery,  had  T2  and  T3  tumours,  while
nly  40%  of  patients  with  conservative  surgery  had  this
umour  size.  Also,  although  40.5%  of  patients  treated  with
ncoplastic  surgery  received  neoadjuvant  chemotherapy,
he  tumour  size  reported  for  disease  was  signiﬁcantly  higher
s  compared  to  that  in  the  group  of  conservative  surgery.
herefore,  the  tumour  size  was  considerably  higher,  both
linically  and  pathologically  in  the  group  of  oncoplastic
urgery,  regardless  of  the  fact  that  there  was  no  difference
n  the  gland  size  reported  between  both  groups.  There-
ore,  through  the  oncoplastic  techniques,  the  number  of
atients  treated  with  conservative  surgery  was  increased,
arger  tumours  were  resected  with  no  relevant  aesthetic
efects,  and  it  was  proved  that  neoadjuvant  chemotherapy
s  an  extremely  useful  tool  to  improve  the  breast-tumour
atio.
Surgical  margins  were  higher  in  conservative  surgery,
lthough  those  for  the  group  of  oncoplastic  surgery  are  still
ufﬁcient  for  oncology  purposes.15 The  same  positive  mar-
ins  rate  exists  for  both  groups,  2  patients  for  each  group,
or  whom  the  mastectomy  was  the  applicable  treatment.
egative  margin  rates  have  been  reported  for  only  81%  in
ncoplastic  surgery,  although  in  this  study,  a  97.4%  rate  is
roved.11
In  oncoplastic  surgery,  a  longer  surgical  time  is  expected,
nd  higher  operative  bleeding  due  to  the  surgical  tech-
iques  used,  such  as  movement  of  ﬂaps,  the  areola-nipple
omplex,  or  symmetrisation  of  contralateral  breast.  Despite
his,  there  were  no  complications  during  or  after  surgery  and
one  of  the  patients  included  in  this  study  required  blood
ransfusions.
Also,  it  is  worth  noting  that,  although  more  complex  sur-
ical  techniques  are  used  in  oncoplastic  surgery,  no  patient
ad  delays  in  beginning  adjuvant  chemotherapy  or  radio-
herapy.  Likewise,  the  rate  of  complications  was  very  similar
n  both  surgical  groups  (16.8--18.4%),  slightly  lower  than  that
eported  in  other  studies  with  rates  of  up  to  24%.7,16
Patients  with  positive  margins  in  the  group  of  oncoplastic
urgery  were  treated  with  mastectomy  afterwards,  but  a
roadening  of  margins  has  been  described  in  2  more  cases,
s  a  feasible  treatment  in  this  subgroup  of  patients.17 It  has
een  stated  that  the  mastectomy  rate  for  positive  margins
fter  oncoplastic  surgery  is  between  3  and  16%,  while  in  this
tudy  it  is  2.6%.18
A  recurrence  rate  after  oncoplastic  surgery  from  2  to
%  has  been  reported,  while  in  conservative  surgery  it  is
0--14%.9 So  far,  there  were  no  local  recurrences  in  patients
reated  with  oncoplastic  surgery  included  in  the  study,  and
nly  one  in  the  group  of  conservative  surgery.  But,  ulti-
ately,  a  longer  follow-up  period  is  recommended.
Consistent  with  other  studies,  it  has  been  shown  that
ncoplastic  surgery  has  a  high  acceptance  rate  by  patients,
erived  from  its  excellent  aesthetic  result  and  a  low  impact
n  patients’  everyday  life.  Fitoussi  et  al.11 report  rates  with
ood  results  as  regards  aesthetics,  close  to  93%.  We  show
hat  patients’  quality  of  life,  their  self-esteem  and  socialS.  Sherwell-Cabello  et  al.
evelopment  are  minimally  affected  after  oncoplastic  sur-
ical  treatment.
As  mentioned  before,  oncoplastic  surgery  is  ideal  for
atients  with  some  degree  of  breast  ptosis,  or  breast  hyper-
rophy,  since  these  conditions  can  be  corrected  through
hese  patterns,  avoiding  or  relieving  back  pain  derived
rom  these  diseases,  as  well  as  offering  a safe  oncologic
reatment.19
It  is  therefore  feasible  to  resect  larger  tumours  with
roper  oncologic  margins,  where  these  could  probably  not
ave  been  resected  with  conventional  conservative  surgery
ithout  major  aesthetic  defects.
onclusion
his  study  demonstrates  the  feasibility  and  high  aesthetic
atisfaction  of  oncoplastic  surgery  with  a  minimum  social
nd  psychological  impact  on  patients.  Comparatively,  in  the
roup  of  oncoplastic  surgery,  larger  tumours  were  resected
ith  oncological  satisfactory  margins,  despite  there  being  no
ifferences  in  the  gland  size  between  both  groups.  Resection
f  larger  tumours  was  possible  with  no  major  aesthetic
efects.  The  number  of  patients  treated  with  conservative
urgery  can  be  increased  with  oncoplastic  techniques.
It  is  even  possible,  through  this  approach,  to  treat  breast
onditions  such  as  hypertrophy  or  breast  ptosis.  On  the  other
and,  by  carrying  out  more  limited  resections  in  the  group
f  conventional  conservative  surgery,  the  aesthetic  impact
t  the  breast  level  should  consequently  be  lower.
Although  oncoplastic  surgery  requires  a  more  challeng-
ng  surgical  technique,  operating  time  was  not  signiﬁcantly
igher  and  the  rate  of  complications  was  similar  in  both
roups.  The  quality  of  life,  self-esteem  and  social  develop-
ent  of  patients  with  oncoplastic  surgery  are  only  slightly
ffected  after  the  surgery.
Although  the  follow-up  has  been  nearly  2  years  with  no
ecurrences  so  far  in  the  study  group,  a  longer  period  is
ecessary  to  assess  long  term-recurrence  and  survival  rates.
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